Adrenal disorders in pregnancy

Endocrinology and Metabolism Clinics of North America

Volumn 40, Issue 4, 2011, Pages 779-794

  Abdelmannan, Dima ^a   Aron, David C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addison disease; Adrenal tumor; Cushing syndrome; Hyperaldosteronism; Pheochromocytoma; Pregnancy

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; HYDROCORTISONE; LEVOTHYROXINE; PHENOXYBENZAMINE; PREDNISOLONE; PROPRANOLOL;

ADDISON DISEASE; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL DISEASE; ADRENAL INCIDENTALOMA; ADRENAL INSUFFICIENCY; ADRENALECTOMY; AUTOIMMUNE ADDISON DISEASE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DRUG DOSE INCREASE; HUMAN; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADRENAL INSUFFICIENCY; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; HYPOTHALAMUS; PHEOCHROMOCYTOMA; PITUITARY GLAND; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 82855161029     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2011.09.001     Document Type: Review

References (77)

1. Aron D.C. Diagnostic implications of adrenal physiology and clinical epidemiology for evaluation of glucocorticoid excess and deficiency. Endocrinology 2000, Saunders, Philadelphia. L.J. DeGroot, J.L. Jameson (Eds.).
2. Findling J., Raff H. Cushing's syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab 2009, 91(10):3746-3753.
3. Chrousos G.P., Torpy D.J., Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive systems: clinical implications. Ann Intern Med 1998, 129:229-240.
4. Lindsay J., Jonklaas J., Oldfield E., et al. Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 2005, 90(5):3077-3083.
5. Lindsay J., Nieman L. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005, 26(6):775-799.
6. Magiakou M.A., Mastorakos H., Rabin D., et al. The maternal hypothalamic-pituitary-adrenal axis in third trimester human pregnancy. Clin Endocrinol (Oxf) 1996, 44:419-428.
7. Magiakou M.A., Mastorakos G., Webster E., et al. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann N Y Acad Sci 1997, 816:42-56.
8. Nolten W.E., Lindheimer M.D., Rveckert P.A., et al. Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 1980, 31:466-472.
9. Cousins L., Rigg L., Hollingsworth D., et al. Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy. Am J Obstet Gynecol 1983, 145:411-416.
10. Campbell E.A., Linton E.A., Wolfe C.D., et al. Plasma corticotrophin-releasing hormone concentration during pregnancy and parturition. J Clin Endocrinol Metab 1987, 64:1054-1059.
11. Robinson B.G., Emanuel R.L., Frim D.M., et al. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 1988, 85:5244-5248.
12. Trainer P.J., Woods R.J., Korbonits M., et al. The pathophysiology of circulating corticotropin-releasing hormone-binding protein levels in the human. J Clin Endocrinol Metab 1998, 83:1611-1614.
13. Escher G. Hyperaldosteronism in pregnancy. Ther Adv Cardiovasc Dis 2009, 3(2):123-132.
14. Björnsdottir S., Cnattingius S., Brandt L., et al. Addison's disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 2010, 95(12):5249-5257.
15. Arlt W., Alliolo B. Adrenal insufficiency. Lancet 2003, 361:1881-1893.
16. Girling J., Martineau M. Thyroid and other endocrine disorders in pregnancy. Obstet Gynaecol Reprod Med 2010, 20(9):265-271.
17. Suri D., Moran J., Hibbbard J., et al. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J Clin Endocrinol Metab 2006, 9(10):3866-3872.
18. Otta C., de Mereshian P., Iraci G., et al. Pregnancies associated with primary adrenal insufficiency. Fertil Steril 2008, 90(4):e17-e20.
19. Cohen M. Addison's disease complicated by toxemia of pregnancy. Review of the literature. Arch Intern Med 1948, 81(6):879-887.
20. Lewandowski K., Hincz P., Grzesiak M., et al. New onset Addison's disease presenting as prolonged hyperemesis in early pregnancy. Ginekol Pol 2010, 81(7):537-540.
21. Hahner S., Loeffier M., Bleicken B., et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 2010, 162(3):597-602.
22. Abdelmannan D., Aron D.C. Special aspects of Cushing's syndrome: pregnancy. Contemporary endocriminology: Cushing's syndrome: pathophysiology, diagnosis and treatment 2010, 259-271. Springer, New York. M.D. Bronstein (Ed.).
23. Keely E. Endocrine causes of hypertension in pregnancy-when to start looking for zebras. Semin Perinatol 1998, 22(6):471-484.
24. Kreisberg R. Clinical problem-solving. Half a loaf. N Engl J Med 1994, 330(18):1295-1299.
25. Ross E.J., Linch D.C. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982, 2:646-649.
26. Nieman L.K., Biller B.M., Findling J.W., et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008, 93(5):1526-1540.
27. Scott E.M., McGarrigle H.H., Lachelin C.L. The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. J Clin Endocrinol Metab 1990, 71:639-644.
28. Billaud L., Sanson M.L., Guilhaume B., et al. Cushing syndrome during pregnancy. New diagnostic methods used in 3 cases of adrenal cortex carcinoma. Presse Med 1992, 21(42):2041-2045.
29. Resnek R.M., Armstrong P. The adrenal gland. Clin Endocrinol 1994, 40:561-576.
30. Wieseler K.M., Bhargava P., Kanal K.M., et al. Imaging in pregnant patients: examination appropriateness. Radiographics 2010, 30(5):1215-1229.
31. Close C.F., Mann M.C., Watts J.F., et al. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf) 1993, 39(3):375-379.
32. Margulies P.L., Imperato-McGinley J., Arthur A., et al. Remission of Cushing's syndrome during pregnancy. Int J Gynaecol Obstet 1983, 21(1):77-83.
33. Parra A., Cruz-Krohn J. Intercurrent Cushing's syndrome and pregnancy. Am J Med 1966, 40(6):961-966.
34. Verdugo C., Donoso J., Meza H., et al. Cushing's syndrome and pregnancy with spontaneous remission after delivery. Rev Med Chil 1982, 110(6):564-569.
35. Polli N., Giraldi F., Cavagnini F. Cushing's disease and pregnancy. Pituitary 2004, 7:237-241.
36. Pinette M.G., Pan Y.Q., Oppenheim D., et al. Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing's syndrome. Am J Obstet Gynecol 1994, 171(2):563-564.
37. Hillman D.A., Giroud C.J. Plasma cortisone and cortisol levels at birth and during the neonatal period. J Clin Endocrinol Metab 1995, 25:243-248.
38. Fitzsimons R., Greenberger P.A., Patterson M.D. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 2009, 78:349-353.
39. Sonino N., Boscaro M. Medical therapy for Cushing's disease. Endocrinol Metab Clin North Am 1999, 28:211-222.
40. Hamilton E., o'Callaghan C., O'Brien R., et al. Familial hyperaldosteronism type 1 in pregnancy. Intern Med J 2009, 39(2):135-136.
41. Wyckoff J.A., Seely E.W., Hurwitz S., et al. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000, 35:668-672.
42. Refaat M., Idriss S., Blaszkowsky L. Case report: an unusual case of adrenal neuroblastoma in pregnancy. Oncologist 2008, 13(2):152-156.
43. Wolf A., Goretzki P., Rõhrborn A., et al. Pheochromocytoma during pregnancy: laparoscopic and conventional surgical treatment of two cases. Exp Clin Endocrinol Diabetes 2004, 112:98-101.
44. Kamari Y., Sharabi Y., Leiba A., et al. Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens 2005, 18:1306-1312.
45. Finkenstedt G., Gasser R.W., Hofle G. Pheochromocytoma and sub-clinical Cushing's syndrome during pregnancy: diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 1999, 22(7):551.
46. Schenker J., Chowers I. Pheochromocytoma and pregnancy: review of 89 cases. Obstet Gynecol 1971, 26:739-747.
47. Kariya N., Nishi S., Hosono Y., et al. Cesarean section at 28 weeks' gestation with resection of pheochromocytoma: perioperative antihypertensive management. J Clin Anesth 2005, 17:296-299.
48. Junglee N., Harries S., Davies N., et al. Pheochromocytoma in pregnancy: when is operative intervention indicated?. J Womens Health (Larchmt) 2007, 16:1362-1365.
49. Griffin J., Norman P., Douvas P., et al. Pheochromocytoma in pregnancy: diagnosis and collaborative management. South Med J 1984, 77:1325-1327.
50. Asensio M.M., Pavon B., Barrena S., et al. Rev Esp Anestesiol Reanim 2009, 56:129-131. [in Spanish].
51. Kennelly M., Ball S., Robson V., et al. Difficult alpha-adrenergic blockade of a phaeochromocytoma in a twin pregnancy. J Obstet Gynaecol 2007, 27:729-730.
52. Kondziella D., Lycke J., Szentgyorgy E. A diagnosis not to miss: pheochromocytoma during pregnancy. J Neurol 2007, 254:1612-1613.
53. Ahlawat S., Jain S., Kumari S., et al. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 1999, 54:728-737.
54. Dugas G., Fuller J., Singh S., et al. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can J Anaesth 2004, 51:134-138.
55. Oliva R., Angelos P., Kaplan E., et al. Pheochromocytoma in pregnancy: a case series and review. Hypertension 2010, 2010(600):606.
56. Stenstrom G., Sjostrom L., Smith U. Diabetes mellitus in phaeochromocytoma: fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol 1984, 106:511-515.
57. Santeiro M.L., Stromquist C., Wyble L. Phenoxybenzamine placental transfer during the third trimester. Ann Pharmacother 1996, 30(11):1249-1251.
58. Lau J., Balk E., Rothberg M., et al. Management of clinically inapparent adrenal mass 2002, Evidence Report/Technology Assessment, Number 56 [pamphlet], Agency for Healthcare Research and Quality, Rockville (MD).
59. Aron D.C. Endocrine incidentalomas. Endocrinol Metab Clin North Am 2002, 29:1-238.
60. Grumbach M., Biller B., Braunstein G., et al. Management of the clinically inapparent adrenal mass (" incidentaloma" ). Ann Intern Med 2003, 138(5):424-429.
61. Anagnostis P., Karagiannis A., Tziomalos K., et al. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) 2009, 8(3):163-184.
62. Aron D., Kievit J. Adrenal Incidentalomas. Endocrine Surgery 2004, 411-427. Marcel Dekker, New York. A.E. Schwartz, D. Pertsemlidis, M. Gagner (Eds.).
63. Bertherat J., Mosnier-Pudar H., Bertagna X. Adrenal incidentalomas. Curr Opin Oncol 2002, 14:58-63.
64. Mansmann G., Lau J., Balk E., et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004, 25:309-340.
65. Mantero F., Albiger N. A comprehensive approach to adrenal incidentalomas. Arq Bras Endocrinol Metabol 2004, 48:583-591.
66. Nawar R., Aron D. Adrenal incidentalomas-a continuing management dilemma. Endocr Relat Cancer 2005, 12:585-598.
67. Terzolo M., Bovio S., Pia A., et al. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 2009, 23:233-243.
68. Young W.F. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000, 29:159-185.
69. Nieman L. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab 2010, 95(9):4106-4113.
70. Berland L., Silverman S., Gore R., et al. Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee. Am Coll Radiol 2010, 7:754-773.
71. Holgersen L.O., Subramanian S., Kirpekar M., et al. Spontaneous resolution of antenatally diagnosed adrenal masses. J Pediatr Surg 1996, 31(1):153-155.
72. Outwater E.K., Siegelman E.S., Radecki P.D., et al. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 1995, 165(3):579-583.
73. Outwater E.K., Siegelman E.S., Huang A.B., et al. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996, 200(3):749-752.
74. Wan Y.L. Ultrasonography of the adrenal gland. J Med Ultrasound 2007, 15(4):213-227.
75. Fontana D., Porpiglia F., Destefanis P., et al. What is the role of ultrasonography in the follow-up of adrenal incidentalomas? The Gruppo Piemontese Incidentalomi Surrenalici. Urology 1999, 54(4):612-616.
76. Fallo F., Pezzi V., Sonino N., et al. Adrenal incidentaloma in pregnancy: clinical, molecular and immunohistochemical findings. J Endocrinol Invest 2005, 28(5):459-463.
77. Joint LWPES/ESPE CAH Working Group Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 2002, 87(9):4048-4053.